CRBU FY 2020 Earnings — Caribou Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CRBUCaribou Biosciences, Inc.

$181M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+113.6% YoY

Gross Profit

-$22M-178.5% margin

Operating Income

-$36M-292.2% margin

Net Income

-$34M-277.6% margin

EPS (Diluted)

$-1.24

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$35M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$36M

Total Liabilities

$59M

Stockholders' Equity

-$23M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$6M	+113.6%
Gross Profit	-$22M	$6M	-481.2%
Operating Income	-$36M	-$34M	-5.3%
Net Income	-$34M	-$23M	-46.4%